Page last updated: 2024-09-03

ethyl 4-isothiocyanatobutanoate and Fibrosarcoma

ethyl 4-isothiocyanatobutanoate has been researched along with Fibrosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chalupa, I; Horakova, K; Horvathova, M; Kuricova, M; Liskova, A; Seemannovaa, Z; Sovcikova, A; Tulinska, J1
Floch, L; Horáková, K; Jantová, S; Novotná, L; Stred'anský, M1

Other Studies

2 other study(ies) available for ethyl 4-isothiocyanatobutanoate and Fibrosarcoma

ArticleYear
Immunotoxic and cancerostatic effects of ethyl-4-isothiocyanatobutanoate in female Lewis rats with implanted fibrosarcoma.
    International immunopharmacology, 2002, Volume: 2, Issue:12

    Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Body Weight; Butyrates; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Isothiocyanates; Leukocytes; Neoplasms, Experimental; Organ Size; Phagocytosis; Rats; Rats, Inbred Lew; Spleen; T-Lymphocytes

2002
Ethyl 4-isothiocyanatobutanoate--antiproliferative activity in vitro and in vivo.
    Anti-cancer drugs, 1993, Volume: 4, Issue:3

    Topics: Animals; Antineoplastic Agents; Butyrates; Cell Division; DNA, Neoplasm; Fibrosarcoma; HeLa Cells; Humans; Isothiocyanates; Lethal Dose 50; Neoplasm Proteins; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; RNA, Neoplasm; Thiocyanates

1993